Login
October 27, 2022 1:00 pm Virtual
America’s innovation system brings countless products from bench to bedside, like life-saving mRNA vaccines. Unfortunately, this lifesaving system is facing unprecedented attacks both domestically and internationally.
For instance, the WTO is considering suspending IP rights on COVID-19 therapeutics and diagnostics. At home, some lawmakers want to misuse the Bayh-Dole Act’s march-in provision as a de facto drug price control mechanism, among other IP limitations.
If successful, this assault on America’s innovation system will hurt R&D, impede investment and jeopardize millions of jobs.
Join this Bayh-Dole Coalition webinar to learn more, Oct. 27 at 1 pm ET
Register/Info